Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have unveiled a paradigm-shifting…
Read More

Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have unveiled a paradigm-shifting…
Read More
The human bone marrow functions as a biological powerhouse, a complex and tireless factory responsible for the generation of millions…
Read More
The effectiveness of groundbreaking therapeutic agents is intrinsically linked to their successful and precise delivery within the human body. Without…
Read More
The pharmaceutical industry is witnessing a significant evolution in oral solid dosage (OSD) development, driven by an increasing demand for…
Read More
Cell and gene therapies (CGTs) have long been heralded for their potential to revolutionize the treatment of complex and previously…
Read More
In the rapidly evolving landscape of life sciences, Polymerase Chain Reaction (PCR) stands as a foundational molecular biology technique, indispensable…
Read More
Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More
Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have fundamentally challenged the…
Read More
The treatment paradigm for locally advanced head and neck squamous cell carcinoma (LA HNSCC) is undergoing a significant transformation, driven…
Read More
The American Association for Cancer Research (AACR) Annual Meeting, held this year in San Diego, CA, USA, from April 17–22,…
Read More